Blog

US Stocks

Most Vulnerable US Stocks & ETFs – 15 December 2022

This is the first post of a new weekly regular feature focusing on some of the most vulnerable issues in the US market, in order to get a broader picture of the overall market health and contribute valuable information to our Weight of Evidence – which is the key to successfully using Stan Weinstein's Stage Analysis method.
Read More

US Stocks Watchlist – 14 December 2022

I'll talk through the watchlist stocks and group themes from the last few days in detail on multiple timeframes during the Stage Analysis midweek video, which will be posted later today (Wednesday).
Read More

US Stocks Watchlist – 12 December 2022

Technology, Industrial and Consumer Discretionary sector groups make up the bulk of todays highlighted stocks, with Semiconductors having the most results, including the group etf – SMH, which has been consolidating above its 30 week MA for the last 6 weeks now, and the 30 week MA has started to flatten out, and the Stage Analysis Technical Attributes (SATA) score has improved to a 6. Hence, the group is in position for a potential Stage 2 breakout attempt if market conditions are favourable.
Read More

Stage Analysis Members Video – 11 December 2022 (1hr 5mins)

The Stage Analysis members weekend video discussing the market breadth charts to determine the weight of evidence, IBD industry group bell curve – percentage above 30 week MA and the bullish percent, industry groups relative strength, market indexes, and the US watchlist stocks in detail on multiple timeframes.
Read More

IBD Industry Groups Bell Curve – Bullish Percent

The IBD Industry Groups Bell Curve declined by -6.50% this week, dropping back into the lower half of the Stage 1 zone (between 40% and 60%). The amount of groups in Stage 4 increased by +22 (+11%), and the amount of groups in Stage 2 decreased by -31 (-15.5%), while the amount groups in Stage 1 or Stage 3 increased by +9 (+4.5%).
Read More